期刊文献+

中药内外治疗对糖尿病足0~1级病变临床疗效的观察 被引量:1

Effects of Chinese Herbal Medicine on the Early Diabetic Foot
下载PDF
导出
摘要 目的:观察中药内服、外洗对糖尿病足0~1级病变的影响。方法:共54例,观察肢端症状体征、血液流变学、血流动力学、血浆内皮素、血管多普勒超声等变化,治疗组30例与对照组24例比较。结果:治疗组有效率86.66%,对照组有效率37.50%,有显著差异(P<0.01)。治疗组临床症状体征有显著改善(P<0.01),踝臂血压指数略有提高,血液流变学各指标有不同程度的降低,血浆内皮素明显降低,血糖、血脂、糖化血红蛋白两组治疗后均明显降低。下肢血管超声显示股动脉、动脉内膜有明显改善。结论:中药在糖尿病足0~1级病变的治疗中起一定的干预作用,尤其对临床症状有明显的改善。 Objective To investigate the effect of Chinese herbal medicine on the early diabetic foot. Methods 54 patients of early diabetic foot were divided into two groups, the therapy group (30 cases) and the control group (24 cases). The clinical symptoms, biochemistry index, hemodynamics, ET, extremity artery color Doppler ultrasound and the speed of nerve conduction were compared in two groups. Results In therapy group chnical symptoms and Anklebrachium index were significantly improved after herbal medication ( P 〈 0.05), and better than the control group ( P 〈 0.05) .The total effective rate was 86.66% for the therapy group while 37.50% for the control group (P 〈0.01) .The hemorheological parameters in the therapy group were significantly lower than those in the control group (P 〈 0.05 ). ET, HbAlc, FPG, 2HPG, TG obviously decreased in beth groups ( P 〈 0.05). The color Doppler ultrasound showed there were obvious difference in intima-media thickness between the two groups (P 〈 0.05 ). Electromyogram showed there were no significantly changes in the two groups. Conclusion- Chinese herbal medicine given internally and applied externally play a fairly role in the early diabetic foot, especially evidence by the improvement of clinical symptoms.
出处 《中国中西医结合外科杂志》 CAS 2005年第6期464-467,共4页 Chinese Journal of Surgery of Integrated Traditional and Western Medicine
关键词 糖尿病足 0~1级 中药治疗 diabetes, diabetic foot, O-ldegree, Chinese herbal medicine
  • 相关文献

参考文献6

二级参考文献12

  • 1李建初 袁光华 等.血管与浅表器官彩色多普勒超声诊断学[M].北京医科大学中国协和医科大学联合出版社,1996.202.
  • 2Ametor AS,Barinov A,Dyck PJ,et al.The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid:the SYDNEY trial.Diabetes Care,2003,26:770-776.
  • 3Cotter MA,Jack AM,Camoron NE.Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes.Clin Sci,2002,103:311-321.
  • 4Hotta N,Toyota T,Matsuoka K,et al.Clinical efficacy of fidarestat,a novel aldose reductase inhibitor,for diabetic peripheral neuropathy:a 52-week multicenter placebo-controlled double-blind parallel group study.Diabetes Care,2001,24:1776-1782.
  • 5Lacomis D.Small-fiber neuropathy.Muscle Nerve,2002,26:173-188.
  • 6Gimbel JS,Richards P,Portenoy RK.Controlled-release oxycodone for pain in diabetic neuropathy:a randomized controlled trial.Neurology,2003,60:927-934.
  • 7Hirai A,Yasuda H,Joko M,et al.Evaluation of diabetic neuropathy through the quantitation of cutaneous nerves.J Neurol Sci,2000,172:55-62.
  • 8Watson CP.The treatment of neuropathic pain:antidepressants and opioids.Clin J Pain,2000,16:S49-S55.
  • 9Vinik A,Pittenger G,Barcus NI,et al.Topiramate improves C-fiber neuropathy and dysmetabolic syndrome in diabetes.J Peripher Nerv Syst,2003,8:201.
  • 10Yuen KC,Baker NR,Rayman G.Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray:a double-blinded placebo-controlledcross-over study.Diabetes Care,2002,25:1699-1703.

共引文献697

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部